165 related articles for article (PubMed ID: 23300153)
21. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
Leslie WD; Martineau P; Bryanton M; Lix LM
Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
[TBL] [Abstract][Full Text] [Related]
22. Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study.
Chapurlat RD; Garnero P; Bréart G; Meunier PJ; Delmas PD
J Bone Miner Res; 2000 Sep; 15(9):1835-41. PubMed ID: 10977003
[TBL] [Abstract][Full Text] [Related]
23. Low serum concentrations of Irisin are associated with increased risk of hip fracture in Chinese older women.
Yan J; Liu HJ; Guo WC; Yang J
Joint Bone Spine; 2018 May; 85(3):353-358. PubMed ID: 28408276
[TBL] [Abstract][Full Text] [Related]
24. Fibrosis markers, hip fracture risk, and bone density in older adults.
Barzilay JI; Bůžková P; Kizer JR; Djoussé L; Ix JH; Fink HA; Siscovick DS; Cauley JA; Mukamal KJ
Osteoporos Int; 2016 Feb; 27(2):815-20. PubMed ID: 26267013
[TBL] [Abstract][Full Text] [Related]
25. Associations of 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D With Bone Mineral Density, Bone Mineral Density Change, and Incident Nonvertebral Fracture.
Swanson CM; Srikanth P; Lee CG; Cummings SR; Jans I; Cauley JA; Bouillon R; Vanderschueren D; Orwoll ES; Nielson CM;
J Bone Miner Res; 2015 Aug; 30(8):1403-13. PubMed ID: 25707402
[TBL] [Abstract][Full Text] [Related]
26. Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.
Crandall CJ; Larson J; Wright NC; Laddu D; Stefanick ML; Kaunitz AM; Watts NB; Wactawski-Wende J; Womack CR; Johnson KC; Carbone LD; Jackson RD; Ensrud KE
JAMA Intern Med; 2020 Sep; 180(9):1232-1240. PubMed ID: 32730575
[TBL] [Abstract][Full Text] [Related]
27. How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS Prospective Study.
Schott AM; Cormier C; Hans D; Favier F; Hausherr E; Dargent-Molina P; Delmas PD; Ribot C; Sebert JL; Breart G; Meunier PJ
Osteoporos Int; 1998; 8(3):247-54. PubMed ID: 9797909
[TBL] [Abstract][Full Text] [Related]
28. Automated DXA-based finite element analysis for hip fracture risk stratification: a cross-sectional study.
Yang S; Leslie WD; Luo Y; Goertzen AL; Ahmed S; Ward LM; Delubac I; Lix LM
Osteoporos Int; 2018 Jan; 29(1):191-200. PubMed ID: 29038836
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory Markers and the Risk of Hip and Vertebral Fractures in Men: the Osteoporotic Fractures in Men (MrOS).
Cauley JA; Barbour KE; Harrison SL; Cloonan YK; Danielson ME; Ensrud KE; Fink HA; Orwoll ES; Boudreau R
J Bone Miner Res; 2016 Dec; 31(12):2129-2138. PubMed ID: 27371811
[TBL] [Abstract][Full Text] [Related]
30. Lower Lean Mass Measured by Dual-Energy X-ray Absorptiometry (DXA) is Not Associated with Increased Risk of Hip Fracture in Women: The Framingham Osteoporosis Study.
McLean RR; Kiel DP; Berry SD; Broe KE; Zhang X; Cupples LA; Hannan MT
Calcif Tissue Int; 2018 Jul; 103(1):16-23. PubMed ID: 29305636
[TBL] [Abstract][Full Text] [Related]
31. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.
Dargent-Molina P; Douchin MN; Cormier C; Meunier PJ; Bréart G;
Osteoporos Int; 2002 Jul; 13(7):593-9. PubMed ID: 12111021
[TBL] [Abstract][Full Text] [Related]
32. Circulating levels of carboxy‐methyl‐lysine (CML) are associated with hip fracture risk: the Cardiovascular Health Study.
Barzilay JI; Bůžková P; Zieman SJ; Kizer JR; Djoussé L; Ix JH; Tracy RP; Siscovick DS; Cauley JA; Mukamal KJ
J Bone Miner Res; 2014; 29(5):1061-6. PubMed ID: 24877243
[TBL] [Abstract][Full Text] [Related]
33. Serum fructosamine level and the risk of hip fracture in elderly women: a case-cohort study within the study of osteoporotic fractures.
Jamal SA; Stone K; Browner WS; Ensrud KE; Cummings SR
Am J Med; 1998 Dec; 105(6):488-93. PubMed ID: 9870834
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein, bone loss, fracture, and mortality in elderly women: a longitudinal study in the OPRA cohort.
Berglundh S; Malmgren L; Luthman H; McGuigan F; Åkesson K
Osteoporos Int; 2015 Feb; 26(2):727-35. PubMed ID: 25410434
[TBL] [Abstract][Full Text] [Related]
35. Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study.
Kim S; Hwang S; Jang HR; Sohn I; Ahn HS; Park HD; Huh W; Jin DC; Kim YG; Kim DJ; Oh HY; Lee JE
BMC Nephrol; 2019 Jun; 20(1):214. PubMed ID: 31185945
[TBL] [Abstract][Full Text] [Related]
36. Lipoprotein(a) plasma levels, bone mineral density and risk of hip fracture: a post hoc analysis of the Women's Health Initiative, USA.
Haring B; Crandall CJ; Carbone L; Liu S; Li W; Johnson KC; Wactawski-Wende J; Shadyab AH; Gass ML; Kamensky V; Cauley JA; Wassertheil-Smoller S
BMJ Open; 2019 Apr; 9(4):e027257. PubMed ID: 31023762
[TBL] [Abstract][Full Text] [Related]
37. Renal function and nonvertebral fracture risk in multiethnic women: the Women's Health Initiative (WHI).
Ensrud KE; Barbour K; Canales MT; Danielson ME; Boudreau RM; Bauer DC; Lacroix AZ; Ishani A; Jackson RD; Robbins JA; Cauley JA
Osteoporos Int; 2012 Mar; 23(3):887-99. PubMed ID: 21625880
[TBL] [Abstract][Full Text] [Related]
38. The association of sex hormone levels with quantitative ultrasound, bone mineral density, bone turnover and osteoporotic fractures in older men and women.
Kuchuk NO; van Schoor NM; Pluijm SM; Smit JH; de Ronde W; Lips P
Clin Endocrinol (Oxf); 2007 Aug; 67(2):295-303. PubMed ID: 17555504
[TBL] [Abstract][Full Text] [Related]
39. Validation of the Cummings' risk score; how well does it identify women with high risk of hip fracture: the Tromsø Study.
Ahmed LA; Schirmer H; Fønnebø V; Joakimsen RM; Berntsen GK
Eur J Epidemiol; 2006; 21(11):815-22. PubMed ID: 17119878
[TBL] [Abstract][Full Text] [Related]
40. Fall-related factors and risk of hip fracture: the EPIDOS prospective study.
Dargent-Molina P; Favier F; Grandjean H; Baudoin C; Schott AM; Hausherr E; Meunier PJ; Bréart G
Lancet; 1996 Jul; 348(9021):145-9. PubMed ID: 8684153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
